Pharma marketers are contending with regulatory whiplash and rising public mistrust under the Trump administration, forcing shifts in media strategy and creative approaches.
Pharma marketers are contending with regulatory whiplash and rising public mistrust under the Trump administration, forcing shifts in media strategy and creative approaches.